Product Information
BRINZOLAMIDE 1% EYE DROPS is a generic product labeled by Sandoz Inc., priced at $9.4893 per ML under NDC 00781601470. Its NADAC has been published 275 times since May 19, 2021.
FDA first approved this application on Apr 1, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/mL
Manufacturer
Sandoz Inc.NDC
00781601470
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
BRINZOLAMIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020816FDA Approved
4/1/1998
TE Code
AB
On Market Since
3/8/2021
Pharmacological Classes
Price Statistics
The NADAC for BRINZOLAMIDE 1% EYE DROPS has been published 275 times since May 19, 2021, and over the history we have for it it has declined 62.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.4893 per ML |
|---|---|
| All-time high | $26.8459 (Apr 13, 2022) |
| All-time low | $9.4893 (Aug 19, 2026) |
| 52-week high | $12.9336 |
| 52-week low | $9.4893 |
| Median price | $15.2611 |
| Average price | $16.3849 |
| Largest weekly change | +26.9% (Aug 21, 2024) |
| Weeks tracked | 275 |
| Tracking since | May 19, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BRINZOLAMIDE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for BRINZOLAMIDE 1% EYE DROPS, manufactured by Sandoz Inc., is $9.4893 per ML (NDC 00781601470), effective Aug 19, 2026.
How has the price of BRINZOLAMIDE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for BRINZOLAMIDE 1% EYE DROPS has declined 62.6%. It has been tracked across 275 weekly CMS publications since May 19, 2021.
What are the highest and lowest recorded NADAC prices for BRINZOLAMIDE 1% EYE DROPS?
Since May 19, 2021, the NADAC for BRINZOLAMIDE 1% EYE DROPS has ranged from a low of $9.4893 (Aug 19, 2026) to a high of $26.8459 (Apr 13, 2022), with a median of $15.2611 per ML.
Are there cheaper alternatives to BRINZOLAMIDE 1% EYE DROPS?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BRINZOLAMIDE 1% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures BRINZOLAMIDE 1% EYE DROPS?
BRINZOLAMIDE 1% EYE DROPS (NDC 00781601470) is labeled by Sandoz Inc., and CMS classifies it as a generic product.